Loading...

BIIB BIOGEN INC Earnings Reports 8-K Filing

BGN

BB

BIOGEN INC

(BIIB)

2025 8-K

Show Summary

Summary

Earnings Releases

Other Special Situation

Debt-Equity Swaps

Financial Statements

Financial Results

Earnings Report

Q3 Financial Results

Earnings Report

Earnings Report

Earnings Reports

Filing Letter with Quantita...

Earnings Reports

Earnings Reports

Filing Letter with Quantita...

Earnings Reports

Acquisition Completed

Credit Agreement for Acquis...

Merger Agreement

Merger Agreement

Earnings Releases

Filing with Quantitative Data

Quantitative Data

Earnings Report

External Links:

Biogen Inc reported a quarterly earnings loss of $1.4 billion, primarily due to a decline in sales of its Alzheimer's drug, Aduhelm, and ongoing costs related to research and development.

AI Assistant

BIOGEN INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.